European Union - English - EMA (European Medicines Agency)

astrazeneca ab - benralizumab - asthma - drugs for obstructive airway diseases, - fasenra is indicated as an add on maintenance treatment in adult patients with severe eosinophilic asthma inadequately controlled despite high-dose inhaled corticosteroids plus long acting β agonists.

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

astrazeneca uk ltd - benralizumab - solution for injection - 30mg/1ml

Israel - English - Ministry of Health

astrazeneca (israel) ltd - benralizumab - solution for injection - benralizumab 30 mg / 1 ml - benralizumab - fasenra is indicated as an add-on maintenance treatment in adult patients with severe eosinophilic asthma inadequately controlled despite high-dose inhaled corticosteroids plus long-acting β-agonists.

Singapore - English - HSA (Health Sciences Authority)

astrazeneca singapore pte ltd - benralizumab - injection, solution - benralizumab 30 mg/ml

Singapore - English - HSA (Health Sciences Authority)

astrazeneca singapore pte ltd - benralizumab - injection, solution - benralizumab 30 mg / ml

Canada - English - Health Canada

astrazeneca canada inc - benralizumab - solution - 30mg - benralizumab 30mg - interleukin antagonists

Canada - English - Health Canada

astrazeneca canada inc - benralizumab - solution - 30mg - benralizumab 30mg - interleukin antagonists

Saudi Arabia - English - SFDA (Saudi Food and Drug Authority)- الهيئة العامة للغذاء والدواء

astrazeneca ab, sweden - benralizumab - solution for injection - 30 mg/ml

Jordan - English - JFDA (Jordan Food & Drug Administration - المؤسسة العامة للغذاء والدواء)

مستودع ادوية شاوي و رشيدات و مسنات - shawi & rushedat drug store - benralizumab 30 mg/1 ml - 30 mg/1 ml

Saudi Arabia - English - SFDA (Saudi Food and Drug Authority)- الهيئة العامة للغذاء والدواء

astrazeneca ab, sweden - benralizumab - solution for injection - 30 mg/ml,